AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.7000
-0.1460 (-17.26%)
At close: Jan 14, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $9.64 million as of January 16, 2026. Its market cap has increased by 117.85% in one year.
Market Cap
9.64M
Enterprise Value
9.68M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.70
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 9.64M, a decrease of -52.77%. That is a compound annual growth rate of -17.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 9.64M | -26.23% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |